Companies / Industrials
RTX
RTX Corporation
Aerospace & Defense
Aerospace & DefenseAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health57
Growth57
Profitability40
Cash generation67
Balance sheet52
Dilution control70
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)11.1%Revenue growth (FY)9.7%Revenue CAGR (3y)9.7%Gross margin—Operating margin10.5%Net margin7.6%Free cash flow margin9.0%R&D / revenue3.2%Stock comp / revenue0.6%Net debt / operating cash flow2.56xCurrent ratio1.03Diluted share count change1.0%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $64.4B | $67.1B | $68.9B | $80.7B | $88.6B |
| Operating income | $5.1B | $5.5B | $3.6B | $6.5B | $9.3B |
| Net income | $3.9B | $5.2B | $3.2B | $4.8B | $6.7B |
| Operating cash flow | $7.1B | $7.2B | $7.9B | $7.2B | $10.6B |
| Capital expenditure | $2.1B | $2.3B | $2.4B | $2.6B | $2.6B |
| Free cash flow | $5.0B | $4.9B | $5.5B | $4.5B | $7.9B |
| R&D | $2.7B | $2.7B | $2.8B | $2.9B | $2.8B |
| Stock-based comp | $442M | $420M | $425M | $437M | $519M |
| Buybacks | $2.3B | $2.8B | $12.9B | $444M | $50M |
| Dividends | $3.0B | $3.1B | $3.2B | $3.2B | $3.6B |
| Cash | $7.8B | $6.2B | $6.6B | $5.6B | $7.4B |
| Total debt | $31.5B | $31.9B | $43.8B | $41.3B | $34.5B |
| Equity | $73.1B | $72.6B | $59.8B | $60.2B | $65.2B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.